Literature DB >> 10583609

Rat complement factor I: molecular cloning, sequencing and expression in tissues and isolated cells.

G Schlaf1, E Rothermel, M Oppermann, H L Schieferdecker, K Jungermann, O Götze.   

Abstract

Factor I (FI) is a regulatory serine protease of the complement system which cleaves three peptide bonds in the alpha-chain of C3b and two bonds in the alpha-chain of C4b thereby inactivating these proteins. The human protein and the recently characterized mouse factor I are heterodimers of about 88,000 MW which consist of a non-catalytic heavy chain of 50,000 MW which is linked to a catalytic light chain of 38,000 MW by a disulphide bond. For the screening of a rat liver cDNA library we used a hybridization probe produced by polymerase chain reaction (PCR) using degenerated primers which corresponded to conserved parts of the human and the murine factor I nucleotide sequences. One of the identified sequences, which had a length of 2243 base pairs (bp), contained the complete coding region and the whole 3' untranslated region. The length of the coding region in rat consisted of 1812 bp followed by a 3' untranslated region of 207 bp including the polyadenylation signal and the beginning of the poly A tail. Comparison of the rat cDNA-derived coding sequence revealed identities of 87% to the mouse and of 78% to the human FI nucleotide sequence. The translation product of rat FI mRNA was 604 amino acid residues (aa) in length with an identity of 85% to the mouse (603 aa) and 69% to the human protein (583 aa). The comparison of the molecular mass predicted by the primary structure and derived from rat FI isolated from rat serum as detected in immunoblot analyses suggested a glycosylation of more than 20% of the total mass of the FI protein. Expression studies using reverse transcription (RT)-PCR assays indicated that FI-specific mRNA could neither be identified in B cells, nor in T cells, monocytes or granulocytes from rat and human peripheral blood nor in rat peritoneal macrophages. These data were in agreement with the results of RT-PCR obtained with several human lymphoma cell lines (Jurkat, MOLT-4, HUT102, Wil 2-NS, Ramos, Raji, U937) all of which were devoid of FI-specific mRNA. In accord with our data from two rat hepatoma cell lines (FAO and H4IIE) and one from man (HepG2) only isolated rat hepatocytes (HC) but neither Kupffer cells (KC), hepatic stellate cells (HSC; Ito cells) nor sinusoidal endothelial cells (SEC) expressed FI-specific mRNA. FI mRNA was also detected in human umbilical vein endothelial cells (HUVEC) and in the uterus and small intestine of the rat. Spleen and lymph nodes did not contain any detectable FI-specific mRNA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583609      PMCID: PMC2326943          DOI: 10.1046/j.1365-2567.1999.00886.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Anaphylatoxin C5a receptor mRNA is strongly expressed in Kupffer and stellate cells and weakly in sinusoidal endothelial cells but not in hepatocytes of normal rat liver.

Authors:  H L Schieferdecker; E Rothermel; A Timmermann; O Götze; K Jungermann
Journal:  FEBS Lett       Date:  1997-04-14       Impact factor: 4.124

2.  Nucleotide sequence of cDNA and derived amino acid sequence of human complement component C9.

Authors:  R G DiScipio; M R Gehring; E R Podack; C C Kan; T E Hugli; G H Fey
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

3.  Structural characterization of factor I mediated cleavage of the third component of complement.

Authors:  A E Davis; R A Harrison
Journal:  Biochemistry       Date:  1982-11-09       Impact factor: 3.162

4.  Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.

Authors:  N Tamura; R A Nelson
Journal:  J Immunol       Date:  1967-09       Impact factor: 5.422

Review 5.  Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

Authors:  S C Ross; P Densen
Journal:  Medicine (Baltimore)       Date:  1984-09       Impact factor: 1.889

6.  Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (factor I) in three hepatoma cell lines.

Authors:  G Goldberger; M A Arnaout; D Aden; R Kay; M Rits; H R Colten
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

9.  Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.

Authors:  J D Lambris; N J Dobson; G D Ross
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.

Authors:  K Whaley
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  3 in total

1.  Characterization of shark complement factor I gene(s): genomic analysis of a novel shark-specific sequence.

Authors:  Dong-Ho Shin; Barbara M Webb; Miki Nakao; Sylvia L Smith
Journal:  Mol Immunol       Date:  2009-05-07       Impact factor: 4.407

2.  Molecular cloning of the complement regulatory factor I isotypes from the common carp (Cyprinus carpio).

Authors:  Miki Nakao; Satomi Hisamatsu; Makiko Nakahara; Yoko Kato; Sylvia L Smith; Tomoki Yano
Journal:  Immunogenetics       Date:  2003-01-15       Impact factor: 2.846

3.  Functional and Expressional Analyses Reveal the Distinct Role of Complement Factor I in Regulating Complement System Activation during GCRV Infection in Ctenopharyngodon idella.

Authors:  Yi Liu; Zhao Lv; Tiaoyi Xiao; Xuewen Zhang; Chunhua Ding; Beibei Qin; Baohong Xu; Qiaolin Liu
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.